Asymptomatic reactivation of JC virus in patients treated with natalizumab
Warnke, C.; Adams, O.; Kieseier, B.C.
New England Journal of Medicine 361(25): 2489; Author Reply 2489-2490
2009
ISSN/ISBN: 0028-4793 PMID: 20050216 Document Number: 629056
Document emailed within 1 workday
Related Documents
Midaglia, L.; Munoz-Garcia, D.; Sopena, B.; Rodriguez-Cerdeira, C. 2011: Skin infection due to Mycobacterium marinum in a patient being treated with natalizumab Revista de Neurologia 52(11): 701-702Martín, E.; Rendón, P.; De Diego, L.; Soria, M.J.; Martínez, M.C.; Martín, L. 2003: Role of lamivudine in the reactivation of hepatitis B virus infection in immunodepressed patients Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 95(11): 804
Qu, Q.; Shen, K.-w. 2012: Hepatitis B virus reactivation in patients receiving chemotherapy with breast cancer Zhonghua Yi Xue Za Zhi 92(34): 2377-2378
Rajcáni, J.; Sabó, A.; Mucha, V.; Kostál, M.; Compel, P. 1995: Herpes simplex virus type 1 envelope subunit vaccine not only protects against lethal virus challenge, but also may restrict latency and virus reactivation Acta Virologica 39(1): 37-49
Villa, E.; Theodossi, A.; Portmann, B.; Eddleston, A.L.; Williams, R. 1981: Reactivation of hepatitis B virus infection in two patients: immunofluorescence studies of liver tissue Gastroenterology 80(5 Part 1): 1048-1053
Janier, M. 2001: Reactivation of herpesvirus 2 genital infection in seropositive asymptomatic subjects Annales de Dermatologie et de Venereologie 128(12): 1385-1388
Jin, D.; Tie, N.; Liu, J.; Zhao, L.; Hao, D.; Zhao, Y. 2015: Investigation of the risk of hepatitis B virus reactivation in arthritis patients undergoing anti-tumour necrosis factor alpha therapy Zhonghua Nei Ke Za Zhi 54(4): 313-316
Pivert, A.; Payan, C.; Lunel, F.; C, E.R.T. A. 2004: Comparaison des cinétiques de l'ARN et de l'antigène de capside du virus de l'hépatite C dans le suivi thérapeutique des patients co-infectés par le virus de l'hépatite C et le virus de l'immunodéficience humaine, traités par bithérapie interféron-ribavirine, dans le cadre du protocole RIBAVIC - Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol Pathologie et Biologie 52(9): 522-528
Terleth, C.; van Laar, T.; Schouten, R.; van Steeg, H.; Hodemaekers, H.; Wormhoudt, T.; Cornelissen-Steijger, P.D.; Abrahams, P.J.; van der Eb, A.J. 1997: A lack of radiation-induced ornithine decarboxylase activity prevents enhanced reactivation of herpes simplex virus and is linked to non-cancer proneness in xeroderma pigmentosum patients Cancer Research 57(19): 4384-4392
Lee, Y.H.; Bae, S.-C.; Song, G.G. 2013: Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy Clinical and Experimental Rheumatology 31(1): 118-121
Epstein, L.M.; Scheinman, M.M. 1990: Should asymptomatic patients with coronary artery disease and nonsustained ventricular tachycardia be treated with antiarrhythmic drugs? Cardiovascular Clinics 21(1): 79
Magarò, M.; Altomonte, L.; Zoli, A.; Mirone, L.; Berchicci, M.C.; Tricerri, A.; Corvino, G. 1989: Asymptomatic and symptomatic gastroduodenal patients affected by rheumatic disease treated with non-steroidal anti-inflammatory drugs Panminerva Medica 31(1): 16-18
Cacopardo, B.; Nunnari, G.; Mughini, M.T.; Tosto, S.; Benanti, F.; Nigro, L. 2003: Fatal hepatitis during Epstein-Barr virus reactivation European Review for Medical and Pharmacological Sciences 7(4): 107-109
Kanmura, S.; Moriuchi, A.; Hamamoto, H.; Ido, A. 2017: Hepatitis B virus reactivation in inflammatory bowel diseases Nihon Rinsho. Japanese Journal of Clinical Medicine 75(3): 461-465
Daikoku, T. 2006: Latent infection and reactivation of Epstein-Barr virus Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 3): 584-588
Popova, E.V.; Brylev, L.V.; Davydovskaia, M.V. 2013: Natalizumab in the treatment of patients with relapsing-remitting multiple sclerosis: the preliminary results of the observational program "Sovet" Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(2 Pt 2): 79-82
Harm, W. 1973: T 4 -mediated v-gene reactivation of UV-irradiated phage Ti, and its comparison with host-cell reactivation Mutation Research 17(2): 163-176
Yamazaki, M. 2016: Measures Against Hepatitis B Virus Reactivation Where Specialist Teams Collaborate Rinsho Byori. Japanese Journal of Clinical Pathology 64(9): 1085-1090
Boulinguez, S.; Rogez, S. 1997: Herpes simplex virus: mechanism of latency and reactivation phases Annales de Dermatologie et de Venereologie 124(5): 409-415
Grotz, W.; Rasenack, J.; Benzing, T.; Berthold, H.; Peters, T.; Walter, E.; Schollmeyer, P.; Rump, L.C. 1998: Occurrence and management of hepatitis B virus reactivation following kidney transplantation Clinical Nephrology 49(6): 385-388